Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
EKF Diagnostics Holdings PLC - Cardiff-based diagnostics and central laboratory assay maker - Posts improved profit for 2021. Pretax profit rises by 39% to £21.4 million from £15.4 million in 2020, as revenue grows 25% to £81.8 million from £65.3 million. Proposes slightly higher dividend of 1.2 pence per share from 1.1p the year before. For the first quarter of 2022, EKF Diagnostics expects a performance in line with 2021. The company sees no benefit from further Covid-related manufacturing and a significant reduction in pandemic-related contracts in 2022.
Current stock price: 43.69 pence, down 14% on Tuesday
12-month change: down 38%
Copyright 2022 Alliance News Limited. All Rights Reserved.